Q1 Results Miss Expectations Amidst Facility Explosion; Q2 Outlook Projects Recovery
ASPN sits 83% above its 52-week low of $2.3.
Summary
Aspen Aerogels reported weaker Q1 2026 financial results and disclosed an explosion at its manufacturing facility, but a significant cash settlement and improving Q2 guidance offer a mixed outlook.
Key Events · Earnings and Guidance · ASPN
-
Q1 2026 Financial Performance
Total revenue for Q1 2026 was $37.9 million, down from $78.7 million in the prior year. The company reported a net loss of $23.7 million, or $0.29 per share, and an adjusted net loss of $23.3 million, or $0.28 per share, significantly wider than the prior year's adjusted loss of $4.8 million.
-
Manufacturing Facility Explosion and Restart
An explosion occurred at the East Providence, Rhode Island manufacturing facility on April 8, 2026, causing damage and a temporary cessation of operations. A staged restart of operations is expected to begin in May, with the company leveraging existing inventory and external manufacturing capacity.
-
Liquidity Boost from GM Settlement
The company received $37.6 million in cash from a commercial settlement with General Motors, contributing to a quarter-end cash balance of $175.6 million, up from $158.6 million at year-end 2025.
-
Q2 2026 Financial Outlook
For Q2 2026, Aspen Aerogels expects revenue to range between $40 million and $48 million, and net loss to be between $14 million and $20 million, indicating a sequential improvement from Q1 results.
Analysis · ASPN · Trade & Services
Aspen Aerogels reported a challenging first quarter with a significant year-over-year decline in revenue and a wider adjusted net loss, primarily due to reduced customer demand and operational disruptions. The disclosure of an explosion at its East Providence manufacturing facility in April, though with a staged restart planned for May, introduces significant operational risk and uncertainty regarding future production capabilities and supply chain resilience. However, a substantial cash infusion from a General Motors settlement has bolstered the company's liquidity, and the Q2 guidance projects sequential improvements in revenue and profitability, suggesting a path to recovery. Investors should monitor the facility restart progress and the company's ability to meet its improved Q2 outlook.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 36.9% of the 964 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.65%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ASPN was trading at $4.21 on NYSE in the Trade & Services sector, with a market capitalization of approximately $341.2M. The 52-week trading range was $2.30 to $9.78. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.